chartexchange

Upstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress

GlobeNewswire Inc. | Nov 10, 2026 7:00 AM EST

– Company plans to initiate Phase 3 trials in both severe asthma and CRSwNP in the first quarter of 2027 –

Read original article